Is TECH a good stock to buy? We came across a bullish thesis on Bio-Techne Corporation on r/ValueInvesting by Dynaheir-be. In ...
Techne’s stock price fell to $51.95. Shareholders have lost 13.8% of their capital, which is disappointing considering the ...
View Bio-Techne Corporation TECH stock quote prices, financial information, real-time forecasts, and company news from CNN.
Bio‑Techne Corporation, a global provider of life science tools, reagents and diagnostic products, and Refeyn, the pioneer in ...
Hollow Brook Wealth Management sold its entire position in Bio-Techne -- 174,677 shares -- during the fourth quarter of 2025, for an estimated $10.7 million based on quarterly average pricing. The ...
Barchart on MSN
Are Wall Street analysts bullish on Bio-Techne stock?
With a market cap of $7.5 billion, Bio-Techne Corporation (TECH) is a global life sciences company that develops, manufactures, and sells reagents, instruments, and services for research, diagnostics, ...
The combined solutions support characterization capabilities for antibodies that cannot be achieved using standalone methods.
RBC Capital on Tuesday upgraded Bio-Techne Corporation (NASDAQ:TECH), noting that recent end-market weakness has over-penalized one of the best assets in the life science and tools (LST) sector, ...
New SPYRE™ Focus Panels (Stroma and Vessel) broaden modular panel options, enabling deeper targeted insights in spatial biology workflows. SPYRE™ Amplification Kits leverage sequential and enhanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results